CXCL14 was upregulated in MF-derived foam cells, and CXCL14 peptide-induced immunotherapy suppresses atherosclerosis in Apoe–/– mice (50), suggesting a proatherogenic role of CXCL14. This evidence concerns the gene APOE and atherosclerosis.